Anti–programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study

Marion Panhaleux, Olivier Espitia, Benjamin Terrier, Guillaume Manson, Alexandre Maria, S. Humbert, B. Godbert, Julie Perrin, Aurélie Achille, Jennifer Arrondeau, Marie Kostine, Vincent Fallet, G. Pugnet, Benjamin Chaigne, Stéphane Champiat, Ariane Laparra, François‐Xavier Danlos, David Launay, Nicolas Penel, Olivier Lambotte, Jean‐Marie Michot, Alexandra Forestier